BridgeBio Pharma (BBIO) News
NASDAQ: BBIOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
65.44+0.40 (+0.62%)
Market open · Delayed 15 min · as of Oct 9, 3:15 PM ET
BBIO news summary
We found 4 recent headlines mentioning BridgeBio Pharma (BBIO): 2 in the past week and 3 in the past 30 days, most often from Nasdaq. For price context, BBIO is up 0.62% at $65.44. The most recent story, "Weekly Buzz: RHHBY, NVS, PFE Win FDA Nod; CRBU Scales Back; PCVX, ABBV Report Positive Trial Data", was published by Nasdaq on Oct 9, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest BridgeBio Pharma headlines
- Weekly Buzz: RHHBY, NVS, PFE Win FDA Nod; CRBU Scales Back; PCVX, ABBV Report Positive Trial Data(RTTNews) - This week, biopharmaceutical companies saw a busy week of regulatory decisions, strategic partnerships and clinical developments, alongside pipeline setbacks and workforce reductions.NasdaqABBV, ALVO, ARGX, BBIO
- BridgeBio Pharma Becomes Oversold (BBIO)Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a…Nasdaq
- Top Analyst Reports for ExxonMobil, Automatic Data Processing & CadenceExxonMobil, ADP and Cadence highlight today's analyst reports, with growth drivers, market risks and strategic moves shaping their outlooks.NasdaqADP, XOM, CDNS, BOF
- Trump's MFN Push Goes Beyond Big Pharma, Adds 9 Mid-Sized DrugmakersTrump's MFN push expands to nine mid-sized drugmakers, bringing 26 companies under agreements covering 89% of the branded drug market.NasdaqTEVA, BBIO, ONC